Health Act 1993 (ACT)

The matter before the court involved a dispute under the Health Act 1993 (ACT), specifically concerning the admissibility of evidence in proceedings before quality assurance committees and the obligations of the Chief Executive Officer (CEO) of a health facility regarding the sharing of information about decisions related to the scope of clinical practice of practitioners. The legal issues centred on whether certain statements and documents made or prepared for quality assurance committees were admissible as evidence in court, and whether the CEO of a health facility could share information about a decision to amend or withdraw the scope of clinical practice of a practitioner with another health facility outside the Australian Capital Territory (ACT).

The court examined the statutory provisions that explicitly exclude certain types of evidence from being admissible in court if they were made in a proceeding before a quality assurance committee or were documents prepared for such committees. The court considered the definitions of key terms within the Act, such as 'quality assurance committee', 'CEO', 'hospital', and 'practitioner', to interpret the scope of the exclusion. Regarding the sharing of information about decisions on the scope of clinical practice, the court found that the CEO could only disclose such information to another health facility if the latter requested it in writing. The court also noted the conditions under which a scope of clinical practice committee could share information with a requesting health facility outside the ACT, ensuring that any personal information was anonymised.

The court concluded that the specified oral statements, documents, and committee reports were not admissible as evidence in court proceedings due to the clear statutory exclusion. It further held that the CEO's obligation to share information about decisions on the scope of clinical practice was contingent upon a written request from the requesting health facility and was subject to specific conditions regarding the form and content of the information shared. The court's decision provided clarity on the admissibility of evidence from quality assurance committees and the procedural requirements for sharing information about clinical practice decisions between health facilities.